Lehmann said: “There’s been a pick-up in big M&A activity in the US since the summer and given the typical time lag between ...

Shares of Kenvue Inc. KVUE slid 1.04% to $17.10 Thursday, on what proved to be an all-around positive trading session for the ...

Texas has long been home to companies that grow not because the government clears the road for them, but because they innovate, compete, and persevere. Kimberly-Clark, based in Irving, is one of those ...

The appointment of Steve Cahillane as the incoming Chief Executive Officer of Kraft Heinz represents far more than a routine executive change. It is a clear ...

Former Kellogg CEO Cahillane, appointed to run Kraft Heinz on Tuesday, oversaw the separation of the Corn Flakes and Pringles ...

Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.

Drug trials offer people with cancer hope and free medicine, but they also create incentives for doctors in private clinics ...

Pfizer, which makes the shot, is fighting a lawsuit from more than 1,000 women who claim the company knew about the risk of meningiomas but failed to warn patients. Meanwhile, former Vice President ...

Kenvue Inc. is dealing with another challenge to a top-selling product as it attempts to close its $40 billion acquisition by ...

In this video, Jonathan A. Bernstein, MD, discusses findings about chronic itch presented at the American College of Allergy, ...

In this video, Jonathan A. Bernstein, MD, discusses his American College of Allergy, Asthma & Immunology Annual Scientific ...